Stock listing

TWSE:6918 A Plus Biotechnology Co Ltd (愛派司) 股價

Follow A Plus Biotechnology Co Ltd into a list and get an email when it puts out news.

Share price · TWSE:6918

$70.70 TWD -2.50 (-3.4%)

Close on Nov 20, 2026

Past year -17.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$68.60 – $71.00 TWDNov 20, 2026
Volume
111,199 sharesNov 20, 2026
Market cap
$2.41B TWDAt the close on Nov 20, 2026 · price × 34.07M shares outstanding
52-week range
$68.30 – $90.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.72M TWDMedian day 25,001 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
A Plus Biotechnology Co Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:6918 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$70.70-2.50-3.4%$70.80$71.00$68.60111,199
$73.20+0.20+0.3%$72.50$73.20$71.6045,839
$73.00-0.80-1.1%$74.40$74.40$72.6015,665
$73.80-0.40-0.5%$73.00$73.80$73.0022,893
$74.200.000.0%$74.20$74.20$74.0012,015
$74.20-0.70-0.9%$75.00$75.00$73.8012,007
$74.90+0.20+0.3%$73.50$74.90$73.5033,040
$74.70+0.50+0.7%$72.60$74.90$72.6052,047
$74.20+2.30+3.2%$75.00$75.00$72.7031,061
$71.90-0.40-0.6%$71.20$71.90$70.6050,077
$72.30-1.20-1.6%$73.00$73.00$72.3015,495
$73.50+0.80+1.1%$72.70$73.70$72.6070,141
$72.70-0.50-0.7%$73.30$73.50$72.6047,721
$73.20+0.20+0.3%$73.20$73.20$72.8021,124
$73.00-1.10-1.5%$74.00$74.00$73.0035,035
$74.10-0.50-0.7%$73.90$74.10$73.508,004
$74.60+0.40+0.5%$75.00$75.00$74.209,600
$74.20+0.70+1.0%$76.00$76.00$73.6035,236
$73.500.000.0%$73.50$73.50$73.500
$73.50-0.50-0.7%$75.00$75.20$73.5051,000
$74.00-0.60-0.8%$75.10$75.20$74.0034,300
$74.600.000.0%$74.30$75.20$74.3026,000
$74.60-0.40-0.5%$75.00$75.20$74.6010,820
$75.00+0.20+0.3%$74.00$75.80$74.0022,000
$74.80-1.00-1.3%$73.60$75.10$73.6018,000
$75.80+0.80+1.1%$75.00$76.20$75.0035,000
$75.00-0.90-1.2%$75.60$75.60$74.2019,017
$75.90+0.40+0.5%$75.00$75.90$75.0039,000
$75.50+1.80+2.4%$73.60$76.90$73.60119,002
$73.70-0.30-0.4%$74.50$74.60$73.70233,000
$74.00+0.20+0.3%$73.50$74.00$73.5093,000
$73.80+0.20+0.3%$74.00$74.00$73.6026,000
$73.60-0.30-0.4%$73.40$73.60$73.1021,000
$73.90-0.40-0.5%$74.30$74.90$73.9031,000
$74.30+0.30+0.4%$74.00$74.40$73.5012,000
$74.00-0.20-0.3%$74.10$74.10$73.5017,000
$74.20-0.90-1.2%$74.00$74.30$74.0016,010
$75.10+0.30+0.4%$74.50$75.40$74.5024,000
$74.80-0.20-0.3%$75.50$75.80$74.505,000
$75.00-0.20-0.3%$75.00$75.00$75.002,000
$75.20+0.30+0.4%$75.00$75.30$75.004,000
$74.90+0.90+1.2%$75.00$77.00$74.0025,000
$74.00+0.50+0.7%$73.50$74.40$73.509,012
$73.50+0.40+0.5%$73.50$73.50$73.503,200
$73.10+0.20+0.3%$72.60$74.10$72.6036,000
$72.90-1.80-2.4%$74.00$74.00$72.9064,100
$74.70-2.70-3.5%$75.50$75.80$73.40111,000
$77.40-0.10-0.1%$77.80$77.80$77.0022,000
$77.50-0.50-0.6%$77.70$77.70$76.9035,000
$78.00+0.20+0.3%$77.70$78.00$77.0018,016
$77.80+0.70+0.9%$77.90$80.00$76.8051,000
$77.10+0.90+1.2%$78.40$78.40$77.1018,000
$76.20-1.40-1.8%$75.80$77.00$75.8020,000
$77.60+0.40+0.5%$77.50$77.80$77.0031,004
$77.20-0.80-1.0%$77.00$77.50$76.9025,002
$78.000.000.0%$79.00$79.00$76.9031,000
$78.00+3.50+4.7%$75.00$80.80$75.00104,005
$74.50+0.50+0.7%$74.60$75.00$74.0025,000
$74.00-0.50-0.7%$74.20$74.20$73.1037,013
$74.50+0.10+0.1%$74.50$74.80$74.0019,000
$74.40+0.40+0.5%$75.90$75.90$74.3077,000
$74.000.000.0%$74.00$74.30$74.0018,000
Ticker
TWSE:6918
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
TWSE
Currency
TWD

A Plus Biotechnology Co Ltd on 6ix

Sector
Health care
Industry
Medical devices & supplies

Valuation

P/E 13.0× against a median of 14.7×: 3rd lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.08B TWD
P/E
13.0×
EV/sales
2.4×
EV/EBITDA
8.6×
Price/book
2.0×
Gross margin
66.8%
Operating margin
24.0%
Net margin
20.9%
Debt to equity
0.1×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
A Plus Biotechnology Co Ltd · TWSE:6918US$73.07MUS$63.19M13.0×2.4×8.6×2.0×20.9%0.1×n/a
Zomedica Corp. · OTC:ZOMDFUS$78.49MUS$71.21Mn/a1.8×n/a0.8×−41.3%0.0×0.10
SkinHealth Systems Inc. · NASDAQ:SKINUS$77.00MUS$228.9Mn/a0.8×8.0×1.4×−6.3%4.7×1.24
Graphy Inc. · KRX:318060US$76.80MUS$76.08Mn/a4.4×n/a6.8×−48.1%0.0×n/a
L&K BIOMED Co., Ltd. · KRX:156100US$76.55MUS$61.13M37.3×2.1×24.3×1.6×6.9%0.0×n/a
Wellell Inc. · TWSE:4106US$73.78MUS$52.11M13.1×0.7×5.4×1.0×7.4%0.1×n/a
C-Rad AB Class B · OMXSTO:CRAD_BUS$72.97MUS$59.62M15.7×1.5×9.1×2.0×11.4%0.0×n/a
CG MedTech Co.Ltd. · KRX:056090US$71.34MUS$72.81M14.7×1.9×20.1×1.0×12.8%0.1×n/a
Covalon Technologies Ltd. · TSXV:COVUS$71.26MUS$57.74M23.3×2.4×16.8×3.2×12.8%0.0×0.60
Sewoonmedical Co., Ltd. · KRX:100700US$70.11M−US$3.91M6.8×−0.1×−0.3×0.6×20.9%0.0×n/a
MITECH Co., Ltd. · KRX:179290US$69.97MUS$21.09M4.6×0.4×1.2×0.7×30.3%0.0×n/a
Median of the othersUS$73.37MUS$60.38M14.7×1.6×8.6×1.2×9.4%0.0×0.60

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue835.9M769.6M675.0M615.5M541.9M
Cost of revenue262.4M234.8M214.4M243.9M195.5M
Gross profit573.5M534.8M460.7M371.5M346.4M
Research and development46.6M53.3M59.5M77.0M63.1M
Selling, general and administrative318.1M299.2M233.4M227.9M237.2M
Operating income208.8M182.3M167.7M66.6M46.1M
Depreciation and amortization27.2M26.7M26.4M24.9M21.4M
EBITDA236.0M209.0M194.1M91.5M67.6M
Interest expense2.17M2.19M2.71M2.66M2.20M
Income before tax216.1M187.6M3.04M68.1M46.1M
Net income169.4M151.1M-11.3M45.7M32.9M
Earnings per share, basic4.964.96-0.371.501.08

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents604.4M361.0M319.1M237.7M305.1M
Short-term investments5.00M31.0M1.00M1.00M1.00M
Receivables177.6M179.0M141.7M145.1M128.9M
Inventory354.5M286.9M283.8M295.7M300.7M
Current assets1.19B896.8M769.6M713.6M761.3M
Total assets1.55B1.18B1.07B1.17B1.21B
Accounts payable41.0M39.4M28.8M42.0M42.1M
Current liabilities198.1M163.3M142.8M173.6M203.3M
Long-term debt82.4M87.2M93.8M116.4M154.0M
Total liabilities284.4M258.3M243.4M296.7M361.9M
Shareholders' equity1.26B919.0M827.9M877.8M843.9M
Shares outstanding34.1M30.5M30.2M30.5M30.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations158.9M161.0M159.1M60.6M53.0M
Capital spending-13.6M-9.13M-9.80M-36.8M-224.9M
Free cash flow145.3M151.8M149.3M23.9M-172.0M
Dividends paid-121.9M-81.5M-21.1M-15.2M-14.3M
Share buybacks-38.7M-16.3M-14.2M0
Change in cash243.4M41.9M81.4M-67.4M15.8M

Open Financials

Cap table

Built by 6ix from A Plus Biotechnology Co Ltd’s releases

Common shares
34,071,000
Fully diluted
34,071,000

Fully diluted

LineShares
Common shares34,071,000

Share count over time

CountShares
Nov 22, 202634,071,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
吳開興4.07M11.8%Oct 31, 2026
威凱國際有限公司2.01M5.8%Oct 31, 2026
李泗銘1.84M5.3%Oct 31, 2026
和銘投資股份有限公司1.04M3.0%Oct 31, 2026
陳昱宏958K2.8%Oct 31, 2026
羅翔煒559K1.6%Oct 31, 2026
菁宏資本股份有限公司517K1.5%Oct 31, 2026
周文獻140K0.40%Oct 31, 2026
駱主安100K0.29%Oct 31, 2026
張靜婷29,0000.08%Oct 31, 2026
All 16 holders
HolderSharesOf the companyAs of
詹雅涵26,0000.08%Oct 31, 2026
柯佩君3,000<0.01%Oct 31, 2026
洪文浚00.00%Oct 31, 2026
王曉雯00.00%Oct 31, 2026
林國基00.00%Oct 31, 2026
吳開興Nov 22, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about A Plus Biotechnology Co Ltd.